In silico identification of public neo-antigens in head and neck Cancer for T cell receptor Engineering: Targeting PI3KCA and TP53 missense mutations. - Zenga J; Himburg HA; Wong SJ; Kearl T; Hematti P; Jin VX; Memon AA; Mathison AJ; Awan MJ (Oral oncology, 2024)